Document and Entity Information
Document and Entity Information - shares | 3 Months Ended | |
Mar. 31, 2016 | Apr. 22, 2016 | |
Document and Entity Information [Abstract] | ||
Entity Registrant Name | AWARE INC /MA/ | |
Entity Central Index Key | 1,015,739 | |
Trading Symbol | awre | |
Current Fiscal Year End Date | --12-31 | |
Entity Filer Category | Accelerated Filer | |
Entity Common Stock, Shares Outstanding | 22,993,139 | |
Document Type | 10-Q | |
Document Period End Date | Mar. 31, 2016 | |
Amendment Flag | false | |
Document Fiscal Year Focus | 2,016 | |
Document Fiscal Period Focus | Q1 |
CONSOLIDATED BALANCE SHEETS (un
CONSOLIDATED BALANCE SHEETS (unaudited) - USD ($) $ in Thousands | Mar. 31, 2016 | Dec. 31, 2015 |
Current assets: | ||
Cash and cash equivalents | $ 52,650 | $ 51,232 |
Accounts receivable, net | 3,839 | 4,743 |
Prepaid expenses and other current assets | 677 | 483 |
Total current assets | 57,166 | 56,458 |
Property and equipment, net | 4,874 | 4,977 |
Investments | 869 | 869 |
Deferred tax assets | 872 | 999 |
Other assets | 261 | 316 |
Total assets | 64,042 | 63,619 |
Current liabilities: | ||
Accounts payable | 616 | 234 |
Accrued expenses | 823 | 952 |
Accrued income taxes | 236 | |
Deferred revenue | 5,102 | 5,885 |
Total current liabilities | 6,541 | 7,307 |
Long-term deferred revenue | $ 311 | $ 131 |
Commitments and contingent liabilities | ||
Stockholders' equity: | ||
Preferred stock, $1.00 par value; 1,000,000 shares authorized, none outstanding | ||
Common stock, $.01 par value; 70,000,000 shares authorized; issued and outstanding 22,993,139 as of March 31, 2016 and 22,935,988 as of December 31, 2015 | $ 230 | $ 229 |
Additional paid-in capital | 103,345 | 102,968 |
Accumulated other comprehensive loss | (67) | (64) |
Accumulated deficit | (46,318) | (46,952) |
Total stockholders' equity | 57,190 | 56,181 |
Total liabilities and stockholders' equity | $ 64,042 | $ 63,619 |
CONSOLIDATED BALANCE SHEETS (u3
CONSOLIDATED BALANCE SHEETS (unaudited) (Parentheticals) - $ / shares | Mar. 31, 2016 | Dec. 31, 2015 |
Statement Of Financial Position [Abstract] | ||
Preferred stock, par value (in dollars per share) | $ 1 | $ 1 |
Preferred stock, shares authorized | 1,000,000 | 1,000,000 |
Preferred stock, shares outstanding | 0 | 0 |
Common stock, par value (in dollars per share) | $ 0.01 | $ 0.01 |
Common stock, shares authorized | 70,000,000 | 70,000,000 |
Common stock, shares issued | 22,993,139 | 22,935,988 |
Common stock, shares outstanding | 22,993,139 | 22,935,988 |
CONSOLIDATED STATEMENTS OF INCO
CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME (unaudited) - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | |
Mar. 31, 2016 | Mar. 31, 2015 | |
Revenue: | ||
Software licenses | $ 2,774 | $ 1,649 |
Software maintenance | 1,282 | 1,153 |
Services | 419 | 1,220 |
Hardware | 286 | |
Royalties | 73 | 101 |
Total revenue | 4,834 | 4,123 |
Costs and expenses: | ||
Cost of software licenses | 243 | |
Cost of services | 213 | 547 |
Cost of hardware | 205 | |
Research and development | 1,649 | 1,435 |
Selling and marketing | 920 | 972 |
General and administrative | 724 | 785 |
Total costs and expenses | 3,954 | 3,739 |
Operating income | 880 | 384 |
Other income | 12 | |
Interest income | 67 | 41 |
Income before provision for income taxes | 947 | 437 |
Provision for income taxes | 312 | 165 |
Net income | $ 635 | $ 272 |
Net income per share - basic (in dollars per share) | $ 0.03 | $ 0.01 |
Net income per share - diluted (in dollars per share) | $ 0.03 | $ 0.01 |
Weighted-average shares - basic (in shares) | 22,993 | 22,866 |
Weighted-average shares - diluted (in shares) | 23,005 | 22,887 |
Comprehensive income: | ||
Net income | $ 635 | $ 272 |
Other comprehensive income (net of tax): | ||
Unrealized gains/(losses) on available for sale securities | (4) | 8 |
Comprehensive income | $ 631 | $ 280 |
CONSOLIDATED STATEMENTS OF CASH
CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2016 | Mar. 31, 2015 | |
Cash flows from operating activities: | ||
Net income | $ 635 | $ 272 |
Adjustments to reconcile net income to net cash provided by operating activities: | ||
Depreciation and amortization | 162 | 145 |
Stock-based compensation | 8 | 21 |
Deferred tax provision on other comprehensive income | 1 | (4) |
Gain on sale of investments | (12) | |
Amortization of premium/(discount) on investments | (3) | (2) |
Changes in assets and liabilities: | ||
Accounts receivable | 904 | 368 |
Prepaid expenses and other current assets | (194) | (514) |
Deferred tax assets | 127 | 185 |
Accounts payable | 382 | (67) |
Accrued expenses | (129) | 13 |
Accrued income taxes | (236) | |
Deferred revenue | (603) | (395) |
Net cash provided by operating activities | 1,054 | 10 |
Cash flows from investing activities: | ||
Purchases of property and equipment | (5) | (14) |
Sales of investments | 529 | |
Purchase of other assets | (320) | |
Net cash provided by (used in) investing activities | (5) | 195 |
Cash flows from financing activities: | ||
Excess tax benefits from stock-based compensation | 430 | 582 |
Payments made for taxes of employees who surrendered shares related to unrestricted stock | (61) | (87) |
Net cash provided by financing activities | 369 | 495 |
Increase in cash and cash equivalents | 1,418 | 700 |
Cash and cash equivalents, beginning of period | 51,232 | 43,985 |
Cash and cash equivalents, end of period | 52,650 | 44,685 |
Supplemental disclosure: | ||
Cash paid for income taxes | $ 275 | $ 5 |
Nature of Business
Nature of Business | 3 Months Ended |
Mar. 31, 2016 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Nature of Business | A) Nature of Business. |
Basis of Presentation
Basis of Presentation | 3 Months Ended |
Mar. 31, 2016 | |
Basis Of Accounting [Abstract] | |
Basis of Presentation | B) Basis of Presentation. The accompanying unaudited consolidated balance sheets, statements of income and comprehensive income, and statements of cash flows reflect all adjustments (consisting only of normal recurring items) which are, in the opinion of management, necessary for a fair presentation of financial position at March 31, 2016, and of operations and cash flows for the interim periods ended March 31, 2016 and 2015. The results of operations for the interim period ended March 31, 2016 are not necessarily indicative of the results to be expected for the year. |
Fair Value Measurements
Fair Value Measurements | 3 Months Ended |
Mar. 31, 2016 | |
Fair Value Disclosures [Abstract] | |
Fair Value Measurements | C) Fair Value Measurements. Cash and cash equivalents, which primarily include money market mutual funds, were $52.7 million and $51.2 million as of March 31, 2016 and December 31, 2015, respectively. We classified our cash equivalents of $43.1 million and $43.0 million as of March 31, 2016 and December 31, 2015 within Level 1 of the fair value hierarchy because they are valued using quoted market prices. Our investments, which consist of high yield corporate debt securities, are also classified within Level 1 of the fair value hierarchy because they are valued using quoted market prices. We categorize our investments as available-for-sale securities, and carry them at fair value in our financial statements. We had $0.9 million of available-for-sale investments as of March 31, 2016 and December 31, 2015. As of March 31, 2016, our assets that are measured at fair value on a recurring basis and whose carrying values approximate their respective fair values include the following (in thousands): Fair Value Measurement at March 31, 2016 Using: Quoted Prices in Significant Other Significant (Level 1) (Level 2) (Level 3) Corporate debt securities $ 869 $ - $ - Money market funds (included in cash and cash equivalents) 43,095 Total $ 43,964 $ - $ - As of December 31, 2015, our assets that are measured at fair value on a recurring basis and whose carrying values approximate their respective fair values include the following (in thousands): Fair Value Measurement at December 31, 2015 Using: Quoted Prices in Significant Other Significant (Level 1) (Level 2) (Level 3) Corporate debt securities $ 869 $ - $ - Money market funds (included in cash and cash equivalents) 43,027 Total $ 43,896 $ - $ - |
Computation of Earnings per Sha
Computation of Earnings per Share | 3 Months Ended |
Mar. 31, 2016 | |
Earnings Per Share [Abstract] | |
Computation of Earnings per Share | D) Computation of Earnings per Share. Net income per share is calculated as follows (in thousands, except per share data): Three Months Ended March 31, 2016 2015 Net income $ 635 $ 272 Weighted average common shares outstanding 22,993 22,866 Additional dilutive common stock equivalents 12 21 Diluted shares outstanding 23,005 22,887 Net income per share – basic $ 0.03 $ 0.01 Net income per share – diluted $ 0.03 $ 0.01 For the three month periods ended March 31, 2016 and 2015, options to purchase 64,034 and 54,034 shares of common stock were outstanding, but were not included in the computation of diluted EPS because the options’ exercise prices were greater than the average market price of the common stock and thus would be anti-dilutive. |
Stock-Based Compensation
Stock-Based Compensation | 3 Months Ended |
Mar. 31, 2016 | |
Disclosure Of Compensation Related Costs, Share-Based Payments [Abstract] | |
Stock-Based Compensation | E) Stock-Based Compensation. Three Months Ended March 31, 2016 2015 Cost of services $ - $ 1 Research and development 1 2 Selling and marketing - - General and administrative operations 7 18 Stock-based compensation expense $ 8 $ 21 Stock Option Grants Unrestricted Stock Grants We granted shares of unrestricted stock in 2016 and 2015 that affected financial results for the three month periods ended March 31, 2016 and 2015. These grants are described below. 2016 Grant. 2015 Grant |
Business Segments
Business Segments | 3 Months Ended |
Mar. 31, 2016 | |
Segment Reporting [Abstract] | |
Business Segments | F) Business Segments We conduct our operations in the United States and sell our products and services to domestic and international customers. Revenues were generated from the following geographic regions for the three months ended March 31, 2016 and 2015 (in thousands): Three Months Ended March 31, 2016 2015 United States $ 3,740 $ 2,488 Brazil 304 726 Rest of world 790 909 $ 4,834 $ 4,123 Revenue by product group for the three months ended March 31, 2016 and 2015 was (in thousands): Three Months Ended March 31, 2016 2015 Biometrics $ 3,285 $ 3,849 Imaging 1,476 173 DSL royalties 73 101 $ 4,834 $ 4,123 |
Recent Accounting Pronouncement
Recent Accounting Pronouncements | 3 Months Ended |
Mar. 31, 2016 | |
Accounting Changes and Error Corrections [Abstract] | |
Recent Accounting Pronouncements | G) Recent Accounting Pronouncements. In November 2015, the FASB issued Accounting Standard Update 2015-17, "Balance Sheet Classification of Deferred Taxes," which requires that deferred tax liabilities and assets be classified as noncurrent in a classified statement of financial position to simplify the presentation of deferred income taxes. The standard is effective prospectively for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2017, with early adoption permitted. We elected to early adopt this standard effective January 1, 2016. While the adoption of the standard did not have a material impact on our consolidated balance sheets, it is worth noting that we reclassified $184,000 of deferred tax assets that were previously included in current assets on our December 31, 2015 consolidated balance sheet. In March 2016, the FASB issued Accounting Standard Update 2016-09, “Improvements to Employee Share-Based Payment Accounting,” which is intended to simplify various aspects of how share-based payments are accounted for and presented in financial statements. The standard is effective prospectively for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2017, with early adoption permitted. We are currently evaluating the effect this standard will have on our consolidated financial statements and related disclosures. With the exception of the standards discussed above, there have been no other recently issued accounting pronouncements that are of significance or potential significance to us that we have not adopted as of March 31, 2016. |
Income Taxes
Income Taxes | 3 Months Ended |
Mar. 31, 2016 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | H) Income Taxes . Income tax expense was $0.3 million and $0.2 million for the three months ended March 31, 2016 and 2015, respectively. Income tax expense in the three month periods of 2016 and 2015 was based on the U.S. statutory rate of 34%, increased by state income taxes, and reduced by permanent adjustments. Income tax expense in 2016 period was also reduced by research tax credits. In the three month period ended March 31, 2016, we utilized deferred tax assets to reduce our tax liability payable to the government. A portion of the deferred tax assets we used comprised cumulative deductions for stock options in excess of book expense. Under income tax accounting rules, that portion of tax benefits attributable to such deductions must be recorded as an adjustment to equity versus a reduction of income tax expense. The tax benefits from such stock-based awards were $0.4 million in the three month period ended March 31, 2016. These tax benefits were recorded as an equity adjustment to additional paid-in capital. As of March 31, 2016, we had a total of $0.9 million of deferred tax assets for which we had recorded no valuation allowance. We will continue to assess the level of valuation allowance in future periods. Should evidence regarding the realizability of tax assets change at a future point in time, the valuation allowance will be adjusted accordingly. In addition to deferred tax assets carried on our balance sheet, we also had net federal and state research and development credit carryforwards available at December 31, 2015 of $5.5 million and $0.1 million. These credits were not recorded as tax assets as they relate to excess stock compensation deductions that may not be recorded as tax assets under generally accepted accounting principles until the amounts have been utilized to reduce our tax liability. To the extent that these assets are used to reduce future taxes, the benefit will be recorded as a reduction to additional paid-in capital. The aforementioned $0.4 million equity adjustment to additional paid-in capital in the three month period ended March 31, 2016 was related to these deferred tax assets. |
Accumulated Other Comprehensive
Accumulated Other Comprehensive Loss | 3 Months Ended |
Mar. 31, 2016 | |
Equity [Abstract] | |
Accumulated Other Comprehensive Loss | I) Accumulated Other Comprehensive Loss. December 31, Increase/ Reclassification March 31, 2015 Decrease Adjustments 2016 Unrealized losses on available for sale securities $ (137 ) $ 31 $ - $ (106 ) Unrealized gains on available for sale securities 40 (35 ) - 5 Net unrealized gains (losses) on available for sale securities (97 ) (4 ) - (101 ) Income tax benefit (expense) on other comprehensive loss 33 1 - 34 Total accumulated other comprehensive loss, net of taxes $ (64 ) $ (3 ) $ - $ (67 ) |
Accounting Policies (Policies)
Accounting Policies (Policies) | 3 Months Ended |
Mar. 31, 2016 | |
Accounting Policies [Abstract] | |
Basis of Presentation | Basis of Presentation. The accompanying unaudited consolidated balance sheets, statements of income and comprehensive income, and statements of cash flows reflect all adjustments (consisting only of normal recurring items) which are, in the opinion of management, necessary for a fair presentation of financial position at March 31, 2016, and of operations and cash flows for the interim periods ended March 31, 2016 and 2015. The results of operations for the interim period ended March 31, 2016 are not necessarily indicative of the results to be expected for the year. |
Fair Value Measurements (Tables
Fair Value Measurements (Tables) | 3 Months Ended |
Mar. 31, 2016 | |
Fair Value Disclosures [Abstract] | |
Schedule of assets measured at fair value on a recurring basis | Fair Value Measurement at March 31, 2016 Using: Quoted Prices in Significant Other Significant (Level 1) (Level 2) (Level 3) Corporate debt securities $ 869 $ - $ - Money market funds (included in cash and cash equivalents) 43,095 Total $ 43,964 $ - $ - Fair Value Measurement at December 31, 2015 Using: Quoted Prices in Significant Other Significant (Level 1) (Level 2) (Level 3) Corporate debt securities $ 869 $ - $ - Money market funds (included in cash and cash equivalents) 43,027 Total $ 43,896 $ - $ - |
Computation of Earnings per S17
Computation of Earnings per Share (Tables) | 3 Months Ended |
Mar. 31, 2016 | |
Earnings Per Share [Abstract] | |
Schedule of net income per share | Three Months Ended March 31, 2016 2015 Net income $ 635 $ 272 Weighted average common shares outstanding 22,993 22,866 Additional dilutive common stock equivalents 12 21 Diluted shares outstanding 23,005 22,887 Net income per share – basic $ 0.03 $ 0.01 Net income per share – diluted $ 0.03 $ 0.01 |
Stock-Based Compensation (Table
Stock-Based Compensation (Tables) | 3 Months Ended |
Mar. 31, 2016 | |
Disclosure Of Compensation Related Costs, Share-Based Payments [Abstract] | |
Schedule of stock-based employee compensation expense included in unaudited consolidated statements of comprehensive income | Three Months Ended March 31, 2016 2015 Cost of services $ - $ 1 Research and development 1 2 Selling and marketing - - General and administrative operations 7 18 Stock-based compensation expense $ 8 $ 21 |
Business Segments (Tables)
Business Segments (Tables) | 3 Months Ended |
Mar. 31, 2016 | |
Segment Reporting [Abstract] | |
Schedule of revenues generated from geographic regions | Three Months Ended March 31, 2016 2015 United States $ 3,740 $ 2,488 Brazil 304 726 Rest of world 790 909 $ 4,834 $ 4,123 |
Schedule of revenue by product group | Three Months Ended March 31, 2016 2015 Biometrics $ 3,285 $ 3,849 Imaging 1,476 173 DSL royalties 73 101 $ 4,834 $ 4,123 |
Accumulated Other Comprehensi20
Accumulated Other Comprehensive Loss (Tables) | 3 Months Ended |
Mar. 31, 2016 | |
Equity [Abstract] | |
Schedule of components of accumulated other comprehensive loss and activity | December 31, Increase/ Reclassification March 31, 2015 Decrease Adjustments 2016 Unrealized losses on available for sale securities $ (137 ) $ 31 $ - $ (106 ) Unrealized gains on available for sale securities 40 (35 ) - 5 Net unrealized gains (losses) on available for sale securities (97 ) (4 ) - (101 ) Income tax benefit (expense) on other comprehensive loss 33 1 - 34 Total accumulated other comprehensive loss, net of taxes $ (64 ) $ (3 ) $ - $ (67 ) |
Fair Value Measurements - Asset
Fair Value Measurements - Assets measured at fair value on a recurring basis (Details) - Fair value on recurring basis - USD ($) $ in Thousands | Mar. 31, 2016 | Dec. 31, 2015 |
Fair Value Measurement, Quoted Prices in Active Markets for Identical Assets (Level 1) | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total assets measured at fair value | $ 43,964 | $ 43,896 |
Fair Value Measurement, Quoted Prices in Active Markets for Identical Assets (Level 1) | Corporate debt securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Corporate debt securities | 869 | 869 |
Fair Value Measurement, Quoted Prices in Active Markets for Identical Assets (Level 1) | Money market funds (included in cash and cash equivalents) | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Money market funds (included in cash and cash equivalents) | $ 43,095 | $ 43,027 |
Fair Value Measurement, Significant Other Observable Inputs (Level 2) | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total assets measured at fair value | ||
Fair Value Measurement, Significant Other Observable Inputs (Level 2) | Corporate debt securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Corporate debt securities | ||
Fair Value Measurement, Significant Unobservable Inputs (Level 3) | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total assets measured at fair value | ||
Fair Value Measurement, Significant Unobservable Inputs (Level 3) | Corporate debt securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Corporate debt securities |
Fair Value Measurements (Detail
Fair Value Measurements (Detail Textuals) - USD ($) $ in Thousands | Mar. 31, 2016 | Dec. 31, 2015 | Mar. 31, 2015 | Dec. 31, 2014 |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Cash and cash equivalents, primarily include money market funds | $ 52,650 | $ 51,232 | $ 44,685 | $ 43,985 |
Fair value on recurring basis | Corporate debt securities | Fair Value Measurement, Quoted Prices in Active Markets for Identical Assets (Level 1) | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Available-for-sale investments | 869 | 869 | ||
Fair value on recurring basis | Money market funds (included in cash and cash equivalents) | Fair Value Measurement, Quoted Prices in Active Markets for Identical Assets (Level 1) | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Cash and cash equivalents, primarily include money market funds | $ 43,100 | $ 43,000 |
Computation of Earnings per S23
Computation of Earnings per Share - Summary of net income per share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands | 3 Months Ended | |
Mar. 31, 2016 | Mar. 31, 2015 | |
Earnings Per Share [Abstract] | ||
Net income | $ 635 | $ 272 |
Shares outstanding: | ||
Weighted average common shares outstanding (in shares) | 22,993 | 22,866 |
Additional dilutive common stock equivalents (in shares) | 12 | 21 |
Diluted shares outstanding (in shares) | 23,005 | 22,887 |
Net income per share - basic (in dollars per share) | $ 0.03 | $ 0.01 |
Net income per share - diluted (in dollars per share) | $ 0.03 | $ 0.01 |
Computation of Earnings per S24
Computation of Earnings per Share (Detail Textuals) - shares | 3 Months Ended | |
Mar. 31, 2016 | Mar. 31, 2015 | |
Options | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Anti-dilutive common stock share purchase (in shares) | 64,034 | 54,034 |
Stock-Based Compensation - Summ
Stock-Based Compensation - Summary of stock-based employee compensation expenses (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2016 | Mar. 31, 2015 | |
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ||
Stock-based compensation expense | $ 8 | $ 21 |
Cost of services | ||
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ||
Stock-based compensation expense | 1 | |
Research and development | ||
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ||
Stock-based compensation expense | $ 1 | $ 2 |
Selling and marketing | ||
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ||
Stock-based compensation expense | ||
General and administrative operations | ||
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ||
Stock-based compensation expense | $ 7 | $ 18 |
Stock-Based Compensation (Detai
Stock-Based Compensation (Detail Textuals) - Unrestricted Stock Grants - 2001 Nonqualified Stock Plan - Directors, officers and employees - USD ($) | 1 Months Ended | 3 Months Ended | 12 Months Ended | |||
Mar. 28, 2016 | Jan. 31, 2016 | Jul. 31, 2015 | Mar. 31, 2015 | Mar. 31, 2016 | Dec. 31, 2015 | |
2015 Grant | ||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||
Number of shares granted (in shares) | 152,000 | |||||
Stock-based compensation expense | $ 682,000 | |||||
Number of shares issued (in shares) | 57,151 | 58,862 | ||||
Number of common stock shares surrendered by employees withholding taxes | 18,849 | 17,138 | ||||
Common stock value surrendered by employees withholding taxes | $ 61,000 | $ 69,000 | ||||
2016 Grant | ||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||
Number of shares granted (in shares) | 152,000 | |||||
Stock-based compensation expense | $ 558,000 | |||||
Stock based compensation expense charged | 8,000 | |||||
Remaining stock based compensation expense | $ 550,000 |
Business Segments - Revenues ge
Business Segments - Revenues generated following geographic regions (Details ) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2016 | Mar. 31, 2015 | |
Segment Reporting Information [Line Items] | ||
Revenue | $ 4,834 | $ 4,123 |
Operating Segments | United States | ||
Segment Reporting Information [Line Items] | ||
Revenue | 3,740 | 2,488 |
Operating Segments | Brazil | ||
Segment Reporting Information [Line Items] | ||
Revenue | 304 | 726 |
Operating Segments | Rest of World | ||
Segment Reporting Information [Line Items] | ||
Revenue | $ 790 | $ 909 |
Business Segments - Summary of
Business Segments - Summary of revenue by product group (Details 1) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2016 | Mar. 31, 2015 | |
Segment Reporting Information [Line Items] | ||
Revenue | $ 4,834 | $ 4,123 |
Operating Segments | Biometrics | ||
Segment Reporting Information [Line Items] | ||
Revenue | 3,285 | 3,849 |
Operating Segments | Imaging | ||
Segment Reporting Information [Line Items] | ||
Revenue | 1,476 | 173 |
Operating Segments | DSL royalties | ||
Segment Reporting Information [Line Items] | ||
Revenue | $ 73 | $ 101 |
Income Taxes (Detail Textuals)
Income Taxes (Detail Textuals) - USD ($) $ in Thousands | 3 Months Ended | ||
Mar. 31, 2016 | Mar. 31, 2015 | Dec. 31, 2015 | |
Operating Loss Carryforwards [Line Items] | |||
Income tax expense (benefit) | $ 312 | $ 165 | |
Income tax U.S. statutory rate | 34.00% | 34.00% | |
Tax benefits from stock-based awards | $ 400 | ||
Deferred tax assets | 900 | ||
Equity adjustment to additional paid-in capital | $ 400 | ||
Federal | Research and development credit carryforwards | |||
Operating Loss Carryforwards [Line Items] | |||
Net federal and state research and development credit carryforwards | $ 5,500 | ||
State | Research and development credit carryforwards | |||
Operating Loss Carryforwards [Line Items] | |||
Net federal and state research and development credit carryforwards | $ 100 |
Accumulated Other Comprehensi30
Accumulated Other Comprehensive Loss - Components of accumulated other comprehensive loss and activity (Details) $ in Thousands | 3 Months Ended |
Mar. 31, 2016USD ($) | |
Accumulated Other Comprehensive Income Loss [Roll Forward] | |
Beginning balance Net unrealized gains (losses) on available for sale securities | $ (97) |
Beginning balance Income tax benefit (expense) on other comprehensive loss | 33 |
Beginning balance Total accumulated other comprehensive loss, net of taxes | (64) |
Increase/Decrease Net unrealized gains (losses) on available for sale securities | (4) |
Increase/Decrease Income tax benefit (expense) on other comprehensive loss | 1 |
Increase/Decrease Total accumulated other comprehensive loss, net of taxes | $ (3) |
Reclassification Adjustments Net unrealized gains (losses) on available for sale securities | |
Reclassification Adjustments Income tax benefit (expense) on other comprehensive loss | |
Reclassification Adjustments Total accumulated other comprehensive loss, net of taxes | |
Ending balance Net unrealized gains (losses) on available for sale securities | $ (101) |
Ending balance Income tax benefit (expense) on other comprehensive loss | 34 |
Ending balance Total accumulated other comprehensive loss, net of taxes | (67) |
Unrealized losses on available for sale securities | |
Accumulated Other Comprehensive Income Loss [Roll Forward] | |
Beginning balance Net unrealized gains (losses) on available for sale securities | (137) |
Increase/Decrease Net unrealized gains (losses) on available for sale securities | $ 31 |
Reclassification Adjustments Net unrealized gains (losses) on available for sale securities | |
Ending balance Net unrealized gains (losses) on available for sale securities | $ (106) |
Unrealized gains on available for sale securities | |
Accumulated Other Comprehensive Income Loss [Roll Forward] | |
Beginning balance Net unrealized gains (losses) on available for sale securities | 40 |
Increase/Decrease Net unrealized gains (losses) on available for sale securities | $ (35) |
Reclassification Adjustments Net unrealized gains (losses) on available for sale securities | |
Ending balance Net unrealized gains (losses) on available for sale securities | $ 5 |